Previous 10 | Next 10 |
Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month PR Newswire ̶ Clinical, Epidemiology and Health Economics and Outcomes Research to Advance Understanding of Treatment P...
--News Direct-- A new study from the National Institute on Alcohol Abuse and Alcoholism shows alcohol-related deaths increased by 25% in 2020 and remained elevated in 2021. As Alcohol Awareness Month comes to a close, learn more about the latest data on alcohol use: https://bit.ly/36s...
Following a massive decline during the previous day, Wall Street attempted to stabilize on Wednesday, ending a choppy session with a mixed performance. The Dow and S&P 500 posted modest gains, while the Nasdaq ended fractionally lower. Even amid the uncertain action, earnings news contrib...
--News Direct-- Minority Health Month fact: Lesbian, gay, bisexual, and transgender (LGBTQ+) adults are more likely to experience a mental health condition than cisgender, heterosexual adults. We encourage our followers to visit NAMI for information and resources designed to...
The following slide deck was published by Alkermes plc in conjunction with their 2022 Q1 earnings call. For further details see: Alkermes plc 2022 Q1 - Results - Earnings Call Presentation
Alkermes plc (ALKS) Q1 2022 Earnings Conference Call April 27, 2022, 8:00 am ET Company Participants Sandra Coombs - SVP, IR & Corporate Affairs Iain Brown - CFO Todd Nichols - CCO Richard Pops - CEO Conference Call Participants Chris Shibutani - Goldman Sachs Vamil Divan - Mizuho Brandon...
Gainers: Vivakor (VIVK) +91%. Digital World Acquisition (DWAC) +33%. Studio City International Holdings (MSC) +31%. Tempest Therapeutics (TPST) +30%. PAVmed (PAVM) +17%. AppTech Payments (APCX) +16%. Priority Technology Holdings (PRTH) +14%. Fusion Pharmaceuticals (FUSN) +14%. Alkermes ...
Shares of Alkermes (NASDAQ: ALKS) were jumping 11.9% as of 12:25 p.m. ET on Wednesday. The solid gain came after the drugmaker announced its first-quarter results before the market open. Alkermes reported Q1 revenue of $278.5 million, up 10.8% year over year. This result handily...
Image source: The Motley Fool. Alkermes (NASDAQ: ALKS) Q1 2022 Earnings Call Apr 27, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Alkermes (ALKS) Q1 2022 Earnings Call Transcript
--News Direct-- While the industry has made great strides in cancer research and treatments, minority groups in the U.S. continue to bear a greater burden of cancers compared with others. Early detection and screenings are two ways to help address disparities and improve outcomes for th...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...